Adamas Pharmaceuticals Inc is categorized under in Emeryville, CA and active since 2000.
Adamas Pharmaceuticals Inc was established in 2000, and today employs 1 to 4, earning $5.000.000 to $9.999.999 per year. This is a business, which does work in the BOTH market, and is classified as a , under code number 3254120 by the NAICS.
If you are seeking more information, feel free to contact Gregory Went, Chief Executive Officer at the company’s single location by writing to 2200 Powell St # 220, Emeryville, California CA 94608 or by phoning (510) 450-3500. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Adamas Pharmaceuticals Inc |
| Contact Person: | Gregory Went, Chief Executive Officer |
| Address: | 2200 Powell St # 220, Emeryville, California 94608 |
| Phone Number: | (510) 450-3500 |
| Website Address: | adamaspharma.com |
| Annual Revenue (USD): | $5.000.000 to $9.999.999 |
| Founded: | 2000 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B & B2C |
| Business Category: | |
| SIC Code: | 2834 |
| NAICS Code: | 3254120 |
| Share This Business: |
Adamas Pharmaceuticals Inc was started in 2000 to provide professional under the SIC code 2834 and NAICS code 3254120. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $5.000.000 to $9.999.999 per annum.
Feel free to contact Gregory Went, Chief Executive Officer for inquiries that concern Adamas Pharmaceuticals Inc by calling the company number (510) 450-3500, as your correspondence is most welcome. Additionally, the physical location of the single location of Adamas Pharmaceuticals Inc can be found at the coordinates 37.83719,-122.301503 as well as the street address 2200 Powell St # 220 in Emeryville, California 94608.
For its online presence, you may visit Adamas Pharmaceuticals Inc’s website at adamaspharma.com and engage with its social media outlets through on Twitter and on Facebook.